Medtronic announced the primary and secondary outcomes of the VenaSeal Spectrum Venous Leg Ulcer study. According to the ...

Rampart IC, a developer of radiation shielding for interventional suites, announced the acquisition of ClearShield, ...

HistoSonics, developer of the Edison histotripsy system, announced 12-month follow-up clinical data from its prospective #HOPE4LI ...

Cordis announced new data from the SUCCESS PTA and SELUTION SFA Japan peripheral studies evaluating the company’s Selution ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

Rampart IC announced the completion of a $21.6 million Series B financing round. The Alabama-based medical technology company ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

Delcath Systems, Inc. announced that it has received clearance from the FDA to initiate patient enrollment of a phase 2 clinical ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

Medtronic announced the release of data from a subgroup analysis of an atherectomy systematic literature review (SLR) that is eva ...